CPX-351
Dokument
Fact Sheet
Spezifizierung
Akute Myeloische Leukämie (AML)
» neu diagnostiziert
» Induktion
Stand
Januar 2021
Dies ist die aktuell gültige Version des Dokuments
1CPX-351, AML-MRC or t-AML, newly diagnosed, induction
1 N - number of patients2 RR - remission rate, in %5 OS - overall survival in months7 SAE - serious adverse events, CTCAE grade 3/48 EFS - Event-Free Survival14 results for control, results for new therapy15 hazard ratio for new therapy16 n. s. not significant19 Complete Remission Rate (CR + CRi)
